Actelion antibiotic misses mark on one study, hits it on another Ruby Khatun Khatun10 Jun 2017 10:54 AM ISTSwiss biotechnology company Actelion on Thursday presented mixed trial results for its antibiotic hopeful cadazolid, saying it met the main goal of...
Hester Biosciences board approves 3 million dollar investment in African arm Ruby Khatun Khatun9 Jun 2017 11:54 AM ISTNew Delhi: Hester Biosciences said its board has approved investing USD 3 million (over Rs 19 crore) in the companys wholly-owned subsidiary, Hester...
Is the Sun Sinking- Dilip Shanghvi loses 14 Billion Dollars in 2 Years Ruby Khatun Khatun9 Jun 2017 11:29 AM ISTBloomberg Report; By Ari AltstedterDilip Shanghvi’s shrinking fortune has become one of the most visible casualties of the troubles hitting India’s...
Vivimed Labs soars on Nil observation from USFDA Ruby Khatun Khatun9 Jun 2017 11:29 AM ISTVivimed Labs gained as USFDA has given zero 483 observations after inspecting the company's API manufacturing facility in Sant Celoni, Spain.The...
Novartis touts new T-cell therapy data in race for FDA approval Ruby Khatun Khatun9 Jun 2017 11:29 AM ISTZURICH: Novartis on Wednesday touted new data from its T-cell therapy CTL019, saying it is on a par with results of experimental molecules from Kite...
Gufic Biosciences gets two patent certificates; stock soars over 5% Ruby Khatun Khatun9 Jun 2017 11:29 AM ISTMumbai: Gufic Biosciences on Monday informed the bourses that it has received two patent certificates from the Intellectual Property India, The Patent...
Unichem lines up Rs 350 crore capex for next two years Ruby Khatun Khatun9 Jun 2017 11:28 AM ISTNew Delhi: Drug firm Unichem Laboratories has lined up a capex of around Rs 350 crore for the next two years as it plans to strengthen R&D...
Strides Shasun Gets USFDA Approval For Parkinsons Drug Ruby Khatun Khatun9 Jun 2017 11:28 AM ISTNew Delhi: Strides Shasun said it has received approval from the US health regulator for Amantadine Hydrochloride, used for the treatment of...
South Korea to fine Novartis unit over unfair drug promotions Ruby Khatun Khatun9 Jun 2017 10:24 AM ISTSouth Korea's antitrust regulator said it would fine Novartis' local unit 500 million won ($444,089) for alleged unfair promotions, in another setback...
Cadila Healthcare beats Lupin to become 2nd most valued pharma company in India Ruby Khatun Khatun8 Jun 2017 2:26 PM ISTNew Delhi: Shares of Cadila Healthcare surged nearly 10 per cent, helping the company overtake Lupin to become the second most valued pharma firm in...
Zydus Cadila gets USFDA nod for mesalamine tablets Ruby Khatun Khatun8 Jun 2017 2:24 PM ISTNew Delhi: Drug firm Zydus Cadila said it has received the US health regulator's nod to market mesalamine tablets, used for the treatment of...
Teva's migraine drug clears another hurdle, aims for launch in 2018 Ruby Khatun Khatun8 Jun 2017 1:27 PM ISTTeva Pharmaceutical Industries Ltd said on Wednesday its experimental drug to prevent migraines cleared another late-stage study, setting it on course...
